ATORVASTATIN CALCIUM: 1085 Clinical Trials, Page 10 of 109

« First Page «…5 …8 9 10 11 12 …15 20 25 … »Last Page »

Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

Condition(s):Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic SyndromeLast Updated:January 23, 2018Completed

Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

Condition(s):Male Erectile Disorder; Prostate Adenocarcinoma; Erectile Dysfunction, CTCAE; ImpotenceLast Updated:April 3, 2023Completed

LIpitor and biGuanide to Androgen Delay Trial

Condition(s):Prostate CancerLast Updated:April 19, 2021Withdrawn

Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

Condition(s):Myotoxicity of Atorvastatin TreatmentLast Updated:December 3, 2014Completed

LY2189265 and Atorvastatin Interaction Study

Condition(s):Healthy VolunteersLast Updated:October 8, 2014Completed

Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention (PCI) Study 2

Condition(s):Coronary Artery Disease; Coronary AngioplastyLast Updated:February 3, 2010Unknown status

Polaris – Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks

Condition(s):Hypercholesterolemia; Coronary Heart DiseaseLast Updated:March 16, 2009Completed

The Efficacy and Safety of Atorva^® 20mg Versus Lipitor^® 20mg

Condition(s):HypercholesterolemiaLast Updated:December 17, 2013Completed

Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells

Condition(s):HIV-1 InfectionLast Updated:August 3, 2021Completed

100

Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine

Condition(s):Primary Immune ThrombocytopeniaLast Updated:September 22, 2022Completed